Abstract

Telomerase is a well-known cancer biomarker, and the reliable and sensitive detection of telomerase activity is of vital significance for cancer diagnosis and treatment. Despite many attempts, the sensitive methods for telomerase activity assay mainly depend on the various nucleic acid amplification, which requires complex primers/probes design and multiple enzymes. In addition, the multiple experimental procedures may introduce false-positive results from cross-contamination of amplification products challenging the reliability of telomerase-based diagnostics detection. Herein, we present a reliable, amplification-free, and sensitive strategy for the detection of telomerase activity based on the self-extension of telomerase and trans-cleavage of CRISPR/Cas12a. In this work, crRNA/Cas12a complexes can specifically target the self-extending telomere-repetitive DNA and activate the typical CRISPR/Cas12a-based fluorescent output system, which allows the detection of telomerase activity in very few cancer cells (5 HeLa cells) without complex primer design and any nucleic acid amplification. Furthermore, the proposed method holds high reliability and specificity in distinguishing tumor cells from normal cells. With these unique features, including high sensitivity and reliability, excellent specificity, and simplicity, this method highlights a great potential for telomerase-related research and broadens the CRISPR-Cas12a-based sensing toolbox.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.